Ranbaxy To Pay $500 Mn To Settle Adulterated Drugs Sale Charges
  • Gaurav Sarkar
  • May 14 2013

In the largest settlement with a generic pharma major over drug safety, Ranbaxy has pleaded guilty to felony charges related to drug safety and will pay $500 million in civil and criminal fines. The company was said to sell adulterated drugs while lying about it to US regulators. Ranbaxy has admitted that it sold batches of drugs that were improperly manufactured, stored and tested.